Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea

por Lee, Ji Yeon, Bu, Seon Hee, Song, EunHyang, Cho, Seongcheol, Yu, Sungbong, Kim, Jungok, Kym, Sungmin, Seo, Kwang Won, Kwon, Ki Tae, Kim, Jin Yong, Kim, Sunghyun, Ahn, Keumyoung, Jung, Nahyun, Lee, Yeonmi, Jung, Yoobin, Hwang, Chankyoung, Park, Sang Won
Publicado 2023

Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

por Seo, Ji-Min, Kang, Bobin, Song, Rina, Noh, Hanmi, Kim, Cheolmin, Kim, Jong-In, Kim, Minsoo, Ryu, Dong-Kyun, Lee, Min-Ho, Yang, Jeong-Sun, Kim, Kyung-Chang, Lee, Joo-Yeon, Lee, Hansaem, Woo, Hye-Min, Kim, Jun-Won, Choi, Jung-Ah, Song, Manki, Tomaszewska-Kiecana, Monika, Wołowik, Anna, Kulesza, Agnieszka, Kim, Sunghyun, Ahn, Keumyoung, Jung, Nahyun, Lee, Soo-Young
Publicado 2022